Cancer ResearchResearch PaperPaywall

B-Vitamins Cut Breast Cancer Risk While Alcohol Cancels the Benefit

A large EPIC cohort study links higher B-vitamin intake to lower breast cancer risk, with alcohol consumption negating the protective effect.

Monday, August 3, 2026 0 views
Published in Am J Clin Nutr
A flat lay of foods rich in B-vitamins — salmon fillet, eggs, leafy greens, and whole grains — arranged on a wooden cutting board in natural light

Summary

A nested case-control study within the EPIC cohort tracked 3,067 breast cancer cases across seven European countries to examine how one-carbon metabolism nutrients and genetics interact with breast cancer risk. Higher intakes of vitamin B2, B12, and an overall B-vitamins score were each independently associated with meaningfully lower breast cancer risk. However, women consuming more than 16 grams of alcohol per day — roughly one to two drinks — lost this protective benefit entirely. A novel genetic finding showed that reduced expression of one-carbon metabolism genes specifically in adipose tissue raised breast cancer risk in premenopausal women but not in postmenopausal women. The study highlights that adequate B-vitamin intake may be a modifiable dietary lever for breast cancer prevention, particularly for women who limit alcohol.

Detailed Summary

One-carbon metabolism (1CM) is a network of biochemical reactions central to DNA synthesis, repair, and methylation — all processes directly implicated in cancer initiation and progression. Despite this biological plausibility, how 1CM-related nutrients and genetic variants jointly shape breast cancer risk has remained poorly defined. This large European study aimed to fill that gap.

Researchers conducted a nested case-control study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, enrolling 3,067 incident breast cancer cases and 3,067 matched controls from seven countries. Dietary intakes of 1CM-related nutrients were measured via country-specific questionnaires, and novel tissue-specific polygenic risk scores (PRS) were built using expression-quantitative-trait-loci data from breast-cancer-relevant tissues including mammary, adipose, hepatic, adrenal, ovarian, and uterine tissues.

Key nutritional findings were clear: higher intakes of vitamin B2, vitamin B12, and a composite B-vitamins score were each inversely associated with breast cancer risk. Crucially, alcohol moderated this relationship — women drinking more than 16 g/day of alcohol showed no protective association from higher B-vitamin intake, suggesting alcohol may functionally impair 1CM pathways enough to negate dietary benefits. On the genetic side, lower expression of 1CM genes specifically in adipose tissue was linked to elevated breast cancer risk in premenopausal women, a pattern absent in postmenopausal women, pointing to hormonally mediated tissue-specific mechanisms.

The findings carry practical significance: B-vitamin adequacy appears to be a genuinely modifiable dietary risk factor for breast cancer, and alcohol consumption may undercut this protection. Clinicians advising women on cancer prevention should consider both B-vitamin status and alcohol habits together.

Important caveats apply. Dietary data relied on self-reported questionnaires with inherent measurement error. The summary is based on the abstract only, limiting assessment of confounding control and subgroup robustness. No gene-nutrient interaction was detected, suggesting dietary and genetic effects operate independently.

Key Findings

  • Higher vitamin B2 intake was associated with a 7% lower breast cancer risk per standard deviation increase (OR 0.93, 95% CI 0.87–0.99).
  • Higher vitamin B12 intake was associated with a 6% lower breast cancer risk per standard deviation (OR 0.94, 95% CI 0.89–0.99).
  • The inverse association between B-vitamins score and breast cancer risk was not observed among women consuming more than 16 g/day of alcohol.
  • Lower expression of 1CM genes in adipose tissue raised breast cancer risk in premenopausal women (OR 1.12, 95% CI 1.02–1.23) but not postmenopausal women.
  • No interaction between dietary B-vitamin scores and polygenic risk scores was detected.

Methodology

Nested case-control design within the EPIC cohort; 3,067 breast cancer cases matched 1:1 to controls from seven European countries. Dietary intakes were assessed via validated country-specific questionnaires, and tissue-specific polygenic risk scores were constructed from eQTL data across six breast-cancer-relevant tissues. Conditional logistic regression was used, adjusting for established breast cancer risk factors.

Study Limitations

The summary is based on the abstract only, limiting full evaluation of confounders, dietary assessment validity, and statistical models. Dietary intake was self-reported via questionnaire, introducing measurement error. The study is observational and cannot establish causation; residual confounding from unmeasured lifestyle factors remains possible.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: